Skip to Primary Navigation Skip to Site Navigation Skip to Main Content All Site Map

3M Drug Delivery Systems Announces New Vice President and General Manager

ST. PAUL, Minn – October 27, 2011 – 3MK Drug Delivery Systems Announces New Vice President and General Manager James Ingebrand brings more than 27 years of experience within 3M to new leadership role

3M Drug Delivery Systems announces the appointment of James Ingebrand as the new Vice President and General Manager after the retirement of his predecessor, James Vaughan. Ingebrand has built a 27-year career at 3M, giving him significant insight into the pharmaceutical and health care industries.

“As Vice President and General Manager, Ingebrand will assume responsibility for the strategic direction of 3M Drug Delivery Systems’ inhalation, transdermal, topical and oral drug delivery devices and components, which are manufactured and sold in more than 60 countries and six continents around the world.”

“We are pleased to have Jim step into this new role within 3M,” said Brad Sauer, Executive Vice President, 3M Health Care Business. “Jim’s depth of knowledge and understanding of the pharmaceutical industry equip him with outstanding tools to cultivate the innovation that 3M Drug Delivery Systems is known for.”

“Ingebrand’s previous positions within the 3M Drug Delivery Systems Division include roles as a Key Account Manager in the United Kingdom, an Inhalation Program Manager and a Six Sigma Black Belt. Ingebrand most recently served as the Global Business Director for the 3M Dental Division and has worked in several other health care divisions of 3M, including the 3M Infection Prevention Division and 3M Health Care Specialties Division.”

“Ingebrand started his career at 3M in 1984 as a marketing analyst in the Corporate Marketing Research Department. He holds a Bachelor of Science degree in Biochemistry, as well as a Masters of Business Administration degree, both from the University of Minnesota.”

About 3M Drug Delivery Systems

3M Drug Delivery Systems partners with pharmaceutical and biotech companies to develop pharmaceuticals using 3M’s inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with regulatory guidance to help bring products to market.  In-house resources, including toxicology, regulatory expertise, quality assurance, operations, and marketed product support, are available for each step of the development and commercialization process. This depth of resources is one reason why more than 50 percent of all metered-dose inhalers worldwide and 80 percent of all transdermal systems in the United States utilize 3M drug delivery technology.  For more information, please visit or call 1-800-643-8086. 

About 3M

3M captures the spark of new ideas and transforms them into thousands of ingenious products. Our culture of creative collaboration inspires a never-ending stream of powerful technologies that make life better. 3M is the innovation company that never stops inventing. With $27 billion in sales, 3M employs about 80,000 people worldwide and has operations in more than 65 countries. For more information, visit or follow @3MNews on Twitter.

3M is a trademark of 3M Company

Mary Kokkien
3M Public Relations and Corporate Communications
(651) 733-8806